Cargando…
Colorectal Cancer Genetics, Incidence and Risk Factors: In Search for Targeted Therapies
Each year, colorectal cancers (CRCs) affect over a quarter of a million people. The risk of developing CRC in industrialized nations is approximately 5%. When the disease is localised, treatment success rates range from 70–90%; however, advanced CRC has a high mortality rate, consistently ranking in...
Autores principales: | Hull, Rodney, Francies, Flavia Zita, Oyomno, Meryl, Dlamini, Zodwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553623/ https://www.ncbi.nlm.nih.gov/pubmed/33116845 http://dx.doi.org/10.2147/CMAR.S251223 |
Ejemplares similares
-
MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets
por: Marima, Rahaba, et al.
Publicado: (2021) -
Artificial intelligence (AI) and big data in cancer and precision oncology
por: Dlamini, Zodwa, et al.
Publicado: (2020) -
Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies
por: Francies, Flavia Zita, et al.
Publicado: (2021) -
Splicing Genomics Events in Cervical Cancer: Insights for Phenotypic Stratification and Biomarker Potency
por: Francies, Flavia Zita, et al.
Publicado: (2021) -
Can the HIV-1 splicing machinery be targeted for drug discovery?
por: Dlamini, Zodwa, et al.
Publicado: (2017)